PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26350096-7	2016	Recent clinical studies have revealed that sorafenib, a pan-RAF and VEGFR inhibitor, has impressive benefits for KRAS mutant lung cancer patients.	Sorafenib	43-52	zinc fingers and homeoboxes 2	Homo sapiens	60-63